only 13 percent of the world's population will initially have access to the sought after drug mix lorson the head of oxfam's inequality policy division told us it's a consequence of pharmaceutical companies seeking to maximize profits it's extremely dangerous for the world because rich nations are monopolizing the supply of a potential paxi but more importantly they're doing deals with big pharmaceutical corporations which are defending their intellectual property and their profits meaning that the supply of vaccines is being artificially may be too and so what we're saying is we need a people's backs not a profit vaccinating we need to see the breaking down of these painting areas and we need to see open sharing of vaccine technology to maximise the supply of safe and effective vaccines all over the world as soon as possible if you think of countries like india or south africa brazil if these countries are not getting access to safe and effective that staying until 2022 then they would have more lockdowns their economies would be huge trouble and many many people will die do not new to

means only 13 percent of the world's population will initially have access to the sought after drug lorson the head of oxfam's inequality policy division then says this is a consequence of pharmaceutical companies seeking to maximize profits. it's extremely dangerous for the world because rich nations monopolizing the supply of a potential breakthrough but more importantly they're doing deals with big promising corporation which are defending their intellectual property and their profits meaning the supply of banks and the fish are limited. so oxfam says there won't be enough vaccines to go around to meet global demand the 5 leading vaccine candidates for which nations across the world of seal the deal currently undergo in the final stages of clinical trials however catch is even if all 5 proved to be a success which according to the charges extremely unlikely around 2 thirds of the world's population will have to wait until at least 2022 on top of potential drug shortages oxfam further says that the vaccine deals lay bare the inequality between prosperous and developing countries most not

that stark contrast to bangladesh and the situation there the figures only one dose and 9 people max lorson again says that prolonged availability of the vaccine in some countries will result in many unnecessary deaths companies like their own or in the us are only selling their backs into very rich countries they're selling it at a very high price somewhere between $16.00 and $35.00 a dose and you have to have 2 doses so that's like $70.00 per person so they are very clear that they they're doing things to make a profit and they want to make money from this vaccine what we're saying is we need a people's backs not a profit really to see. the breaking down of the patent barrier and we need to see open sharing your banks in technology to maximize its applause or so. and effective vaccines all over the world as soon as possible the huge economic and human cost of. a live aid ability the vaccine if you think of countries like india or south africa brazil if these countries are not getting access to safe and effective but staying until 2022 then they would have more lockdowns their economies wo

means only 13 percent of the world's population will initially have access to this sort of drug marks lorson is how the vox firms inequality policy division he told us this is a consequence of pharmaceutical companies seeking to maximize profits. it's extremely dangerous for the world because a rich nation monopolizing the supply of a potential banksy but more importantly they're doing deals with big promise huge corporations which are defending their intellectual property and their profits meaning that the supplying all vaccine is being artificially limited. so bracing to hear they're not saying they won't be enough vaccines to go around to meet global demand the 5 leading vaccine candidates that they are for which nations across the world sealed the deal are currently undergoing the final stage of clinical trials however even if all 5 proved to be a success which according to the charity is extremely unlikely around 2 thirds of the world's population will still have to wait until at least 2022 on top attentional drug shortages oxfam further says that the vaccine deals lay really bare the i